---
schema_version: "secwatch.filing_event.v1"
accession: "0001562762-25-000181"
form_type: "8-K"
ticker: "CHE"
cik: "0000019584"
company_name: "CHEMED CORP"
filed_at: "2025-07-29T23:59:59+00:00"
generated_at: "2026-05-17T23:49:04.918846+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Chemed Q2 adjusted EPS $4.27 (-21.9% YoY); cuts FY2025 guidance; VITAS CEO departs

## Summary
- GAAP EPS $3.57 (-23.2%); adjusted EPS $4.27 (-21.9%); revenue $618.8M (+3.8%).
- VITAS adjusted EBITDA margin ex-Medicare cap 16.2% (-163 bps); Florida cap accrual $16.4M.
- Roto-Rooter adjusted EBITDA margin 21.8% (-517 bps); revenue +0.6% to $222.6M.
- FY2025 adjusted EPS guidance cut to $22.00-$22.30 from $24.95-$25.45; prior year $23.13.
- VITAS CEO Nicholas Westfall resigns eff. July 29, 2025; Joel Wherley named successor.

## SEC filing metadata
- accession: 0001562762-25-000181
- form_type: 8-K
- ticker: CHE
- cik: 0000019584
- company_name: CHEMED CORP
- filed_at: 2025-07-29T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/19584/000156276225000181/0001562762-25-000181-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/19584/000156276225000181/che-20250729x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001562762-25-000181
- JSON: https://secwatch.observer/filing/0001562762-25-000181.json
- Plain text: https://secwatch.observer/filing/0001562762-25-000181.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.